MedPath
TGA Approval

KANUMA sebelipase alfa rce 2 mg/mL injection intravenous infusion vial (274498)

274498

KANUMA sebelipase alfa rce 2 mg/mL injection intravenous infusion vial

Alexion Pharmaceuticals Australasia Pty Ltd

May 18, 2017

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/edd8afce784d0cac4a711860de4f2ab7.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/1730cdf225d33505684de8913e86ff2d.pdf

Active Ingredients

sebelipase alfa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.